Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Impact of Rest Dual–energy Computed Tomography Myocardial Perfusion in Patients with Coronary Artery Disease

STEFAN BAUMANN, MARLON RUTSCH, TOBIAS BECHER, PHILIPP KRYEZIU, HOLGER HAUBENREISSER, NILS VOGLER, CELI ANNE SCHOENIKE, MARTIN BORGGREFE, STEFAN O. SCHOENBERG, IBRAHIM AKIN, THOMAS HENZLER and DIRK LOSSNITZER
In Vivo November 2017, 31 (6) 1153-1157;
STEFAN BAUMANN
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARLON RUTSCH
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOBIAS BECHER
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIPP KRYEZIU
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOLGER HAUBENREISSER
2Institute of Clinical Radiology and Nuclear Medicine, University Medical Centre Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NILS VOGLER
2Institute of Clinical Radiology and Nuclear Medicine, University Medical Centre Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CELI ANNE SCHOENIKE
3Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN BORGGREFE
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN O. SCHOENBERG
2Institute of Clinical Radiology and Nuclear Medicine, University Medical Centre Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IBRAHIM AKIN
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS HENZLER
2Institute of Clinical Radiology and Nuclear Medicine, University Medical Centre Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thomas.henzler@medma.uni-heidelberg.de
DIRK LOSSNITZER
1First Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: To evaluate the hypothesis that patients with suspected coronary artery disease (CAD) assessed using rest dual-energy computed tomography-derived myocardial perfusion imaging (DECT-P), could have fewer invasive coronary angiographies (ICA), showing non-obstructive CAD. Materials and Methods: Patients who had undergone coronary computed tomography angiography (cCTA), rest DECT-P and ICA were analyzed. Results: We evaluated 51 patients (62.7% males, mean age 51.6±12.8 years). Rest DECT-P identified perfusion defects in three (10.7%) of the 28 patients with cCTA negative for luminal stenosis and in 10 (43.5%) of the 23 patients with cCTA positive for luminal stenosis. In total, 21 patients underwent both cCTA and ICA, of which seven (33.3%) showed obstructive CAD. Rest DECT-P revealed false-negative results in four cases (19.1%) and false-positive results in six cases (28.6%). Conclusion: Adding rest DECT-P to cCTA has no incremental diagnostic value over cCTA alone, to exclude haemodynamically significant CAD. Therefore, a rest-stress-DECT-P protocol or a CT-based FFR calculation might be a promising concept to improve diagnostic accuracy in a real clinical setting.

  • Coronary CT angiography
  • coronary artery disease
  • myocardial perfusion imaging
  • dual-energy CT
  • myocardial ischemia

Current guidelines in the management of stable coronary artery disease (CAD) recommend a non-invasive functional test before considering invasive coronary angiography (ICA) for patients with intermediate pre-test probability (1). Due to the high sensitivity and negative predictive value, coronary computed tomography angiography (cCTA) is a clinically-established non-invasive diagnostic imaging modality to rule-out CAD. However, the specificity and positive predictive value of cCTA is still limited due to the poor correlation of cCTA-detected coronary artery stenosis and myocardial ischaemia.

One avenue for assessment of the myocardial blood supply consists of dual-energy computed tomography (DECT) acquisitions during first-pass arterial enhancement. Dual-energy computed tomography-derived myocardial perfusion imaging (DECT-P) is a “one-stop shop” approach closing the gap between anatomical and functional aspects within a single imaging modality and could reduce false-positive results of cCTA (2). As rest DECT-P is derived from the same datasets as standard cCTA, it requires no additional contrast media, radiation exposure, or stress agents, which represents a substantial advantage, when compared to stress protocols. Studies have compared DECT-P with single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), and ICA in rest or rest-stress acquisition with first or second generation dual-source scanners and found an incremental value over cCTA alone (3-6). However, the data for rest-only acquisition in DECT-P is rather sparse and needs further investigation regarding the clinical utility and its effect on patient care in a real clinical setting.

Thus, the purpose of the present study was to test the hypothesis that patients with suspected CAD evaluated using a rest DECT-P strategy would potentially have fewer coronary angiographies without obstructive CAD than patients who were evaluated based on standard cCTA protocols.

Materials and Methods

Patient population, study design and analysis. The Health Insurance Portability and Accountability Act (HIPAA) compliant study-protocol is in accordance with the Declaration of Helsinki and was approved by our local ethics committee. Written informed consent was obtained from all patients. From February 2016 until October 2016 we enrolled 51 patients with suspected CAD and with low to intermediate pre-test probability for CAD in our prospective single-centre study. We selected patients in accordance with the 2013 guidelines of the European Society of Cardiology (ESC) on the management of stable CAD.

Exclusion criteria were: Renal insufficiency, contrast agent allergy, ST-segment elevation or recent left bundle branch block detected in electrocardiography (ECG), known myocardial infarction, percutaneous coronary intervention (PCI) or bypass operation within the past six months, or a significant increase of high-sensitivity-troponin I (>30%). Participants were referred for a standard cCTA in combination with a rest DECT-P for myocardial perfusion assessment. If cCTA showed stenosis that might be of haemodynamic significance or of unclear origin, participants subsequently proceeded to ICA. Finally, in order to test the study, the results of patients with non-obstructive findings in ICA were compared to the results of the same patients' DECT-P findings.

Computed tomography (CT) acquisition protocol. All CT scans were performed using a 192-slice, third-generation, dual-source CT system (Siemens Somatom Force, Forchheim, Germany). The protocol consisted of a non-enhanced, single-energy standard scan for calcium scoring, subsequently followed by a cCTA with dual-energy acquisition (Figure 1A). Acquisition parameters for the non-enhanced scan were: tube voltage 120 kV; detector collimation 2×192×0.6 mm, as well as the use of prospective ECG-triggering. The reconstruction parameters used for calcium scoring were: slice thickness 3.0 mm, increment 1.5 mm and Qr36 iterative reconstruction kernel. Acquisition parameters for the dual-energy cCTA were: tube voltage 90 kV (tube A), tube voltage 150 kV with additional tin filter (tube B) and, for both tube A and tube B, an automatic tube current modulation; detector collimation 2×192×0.6 mm. The reconstruction parameters were: slice thickness 0.6 mm, increment 0.5 mm and Bv40 kernel. All cCTA acquisitions were performed with retrospective ECG-gating and bolus tracking with the trigger region-of-interest (ROI) placed in the descending aorta with a 100 Hounsfield Unit (HU) threshold. No ECG-dependent tube current modulation was applied. Eighty millilitres of intravenous contrast (Imeron® 400, Bracco, Milan, Italy) were administered through an 18 G cubital catheter, which was followed by a 50 ml saline flush. Both were injected at a rate of five ml/sec. Control of cardiac contraction frequency was achieved by intravenous administration of beta-blockers, targeting a heart rate of ≤65 beats/min. Sublingual nitrates were administered to ensure coronary vasodilatation. First-pass DECT-P was reconstructed from the raw data of the cCTA acquisition (Figure 1B).

CT Image analysis. All examinations were evaluated by physicians with expertise in cardiovascular imaging. Evaluation of cCTA was performed using axial images as well as multi-planar and curved reformations. Degree of stenosis in cCTA was quantified according to the Society of Cardiovascular Computed Tomography (SCCT) guidelines, with significant luminal narrowing defined as ≥70% (7).

For evaluation of first-pass DECT-P data, iodine maps were calculated using a dedicated post-processing work station (Syngo.Via VB10B, Siemens Healthcare, Forchheim, Germany). Iodine attenuation was normalized to the left ventricle. Myocardial perfusion defects were defined as circumscribed areas of decreased or absent iodine content within the left ventricular wall, relative to the remainder of the myocardium. Assignment of the affected segment was based on the American Heart Association's 17-segment model of visual assessment of myocardial perfusion defects shown in the diastolic phase.

ICA with measurement of fractional flow reserve (FFR). ICA was performed by an experienced senior interventional cardiologist according to standard procedures (Figure 1C). FFR measurement (PressureWire Certus, St. Jude Medical; St. Paul, Minnesota, USA) was performed during ICA when the haemodynamic significance of a coronary lesion remained visually unclear. A diagnosis of ischaemia could be declared when the FFR was ≤0.80.

Results

We evaluated 51 patients (62.7% males, 51.6±12.8 years) with a mean Agatston score of 145.7±507.6 and a mean updated Diamond-Forrester score of 26.8±13.1%. The amount of administered CT contrast medium was 84.9±13.8 ml and the dose-length product for cCTA was 642.5±154.4 mGy*cm for cCTA and DECT-P. Further baseline characteristics are shown in Table I.

cCTA identified three (5.9%) patients with severe coronary stenosis (≥70%), nine (17.6%) with moderate stenosis (50-69%), six (11.8%) with mild stenosis (25-49%), five (9.8%) with minimal stenosis (<25%) and 28 (54.9%) without luminal stenosis.

Rest DECT-P identified perfusion defects in three (10.7%) of the 28 patients with cCTA negative for luminal stenosis, and in ten (43.5%) of the 23 patients with cCTA positive for luminal stenosis.

In total, 21 patients underwent both cCTA and ICA, seven (33.3%) of whom showed obstructive CAD in ICA defined as visually high-grade stenosis (>70%) or invasive FFR ≤0.80. Rest DECT-P revealed false negative results in four cases (19.1%) and false positive results in six cases (28.6%), regarding ICA results as a reference (Figure 2).

Discussion

Unfortunately, our study results were underwhelming, and demonstrated that adding rest DECT-P to cCTA has no incremental diagnostic value over cCTA alone to exclude haemodynamically significant CAD in patients with low to intermediate pre-test probability for CAD.

While cCTA is an excellent diagnostic method to rule out CAD, its specificity remains relatively low and is unable to spare patients without obstructive CAD unnecessary ICA. In the multi-centre PLATFORM trial, non-invasive functional testing was feasible and a safe alternative to ICA, and was associated with a significantly lower rate of ICA showing no obstructive CAD. Of the 187 PLATFORM patients who underwent ICA, 137 (73.3%) did not show obstructive CAD (8). Following our initial hypothesis, we hypothesized that ICA examination could have potentially been avoided, according to results of the rest DECT-P assessment, in comparison to an evaluation strategy based on standard cCTA.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Case of a 59-year-old female patient with atypical chest pain, and a pretest probability of 20%. (A) cCTA show several moderate stenoses of the LAD (arrows). (B) DECT-P show minor iodine distribution within basal LAD and RCA territory as a sign of haemodynamic significance (arrows). (C) ICA show severe artery disease of all three vessels. Subtotal stenosis of RCA, significant stenosis of the left main trunk (arrow) and 75% stenosis of mid-RCX and ramus marginalis. cCTA: Coronary computed tomography; DECT-P: dual-energy computed tomography-derived myocardial perfusion imaging; LAD: left anterior descending; RCA: right coronary artery; RCX: Ramus circumflexus; ICA: invasive coronary angiography.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Results of DECT-P compared to ICA findings. Rest DECT-P revealed false-negative results in four cases (19.1%) and false-positive results in six cases (28.6%), compared to ICA results, as a reference. DECT-P: Dual-energy computed tomography-derived myocardial perfusion imaging; ICA: invasive coronary angiography.

However, the chosen strategy led to disappointing results, as the rest DECT showed six false-positive results and, even more importantly, four false-negative results, which could lead to serious consequences for patient safety and prognosis. A dual-energy, static first-pass imaging approach makes the mapping of iodine distribution possible, and serves as a surrogate of myocardial perfusion. Additionally, it makes the quantification of myocardial blood supply possible. Like other functional imaging methods, a standard dual-energy cardiac examination is a combination of rest, stress and late enhancement (9). However, the major limitation of this conventional myocardial perfusion remains to be its additional radiation dose, as well as the required use of stress agents. This is associated with greater effort on the part of the medical professional, due to longer duration of examination and monitoring of the patient, and, therefore, is not always feasible in a real clinical setting. For this reason, we decided to use first-pass arterial rest dual-energy CT, which, compared to stress acquisition, does not require further radiation dose, contrast agent or medication, and, thus, is a promising approach. Meinel et al. compared the relative contributions of rest, stress and delayed acquisitions, with the accuracy of DECT-P and demonstrated an impressively high specificity (98.0%) and positive predictive value (94.0%) for rest-only DECT-P (6). Furthermore, they postulate a dose-reduction of 68.0% in a rest approach, compared to comprehensive protocol of rest, stress and late enhancement. Comparison of radiation between static and dynamic perfusion shows higher doses for dynamic protocols (10.1±15.5 mSv, 11.5±3.5 mSV). A direct comparison of the mean radiation dose in our study of 642.5±154.4 mGy*cm to 1399.4±314.2 mGy*cm in a dynamic rest-only approach (10) clearly demonstrates the advantages of static perfusion, with regard to radiation exposure. A further radiation sparing aspect in our study is the use of a recent third-generation dual-source scanner. Dosimetric parameters for cCTA and coronary calcium scoring is lower in third-generation scanners (31.5±8.7 mGy*cm, 22.7±4.9 mGy*cm) than in second-generation scanners (65.4±21.2 mGy*cm, 31.3±8.0 mGy*cm) (11).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Baseline characteristics and findings of coronary computed tomography, myocardial perfusion imaging and invasive coronary angiography.

Osawa et al. provided important contributions to the diagnostic value of DECT myocardial rest perfusion imaging (10). Furthermore, mixed assessment of HU values to detect abnormalities in perfusion is subjected to high tissue variability of HU values, because of deposition of fat or iron in the myocardium. Further studies are required to quantify perfusion defects in dual-energy CT imaging.

There were limitations in our study. First, the study population consists of a small, single-centre cohort, but is comparable with other studies in this research field. Furthermore, enrolment was stopped after non-promising interim analysis. Second, the percentage of haemodynamically-relevant coronary lesions is rather low, which might affect the level of significance. Third, ethically, it was not approved to perform ICA in patients with negative findings in cCTA/DECT-P to avoid complication in the ICA, nor was it approved to perform subsequent cCTA / DECT-P in patients with positive findings in ICA only for research purposes without clinical reason, due to the application of unjustified radiation exposure.

Conclusion

Our study demonstrated that adding rest DECT-P to cCTA did not fulfil our primary hypothesis for an incremental diagnostic value over cCTA alone. Thus, a rest-stress-DECT-P protocol, or a CT-based FFR calculation seems to be a promising concept to improve diagnostic accuracy in a real clinical setting (12).

Acknowledgements

Supported by the DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research) and by the BMBF (Bildungsministerium für Bildung und Forschung - German Ministry of Education and Research).

Footnotes

  • This article is freely accessible online.

  • Conflicts of Interest

    All Authors declare that there are no conflicts of interest.

  • Received August 4, 2017.
  • Revision received August 21, 2017.
  • Accepted August 22, 2017.
  • Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Task Force M,
    2. Montalescot G,
    3. Sechtem U,
    4. Achenbach S,
    5. Andreotti F,
    6. Arden C,
    7. Budaj A,
    8. Bugiardini R,
    9. Crea F,
    10. Cuisset T,
    11. Di Mario C,
    12. Ferreira JR,
    13. Gersh BJ,
    14. Gitt AK,
    15. Hulot JS,
    16. Marx N,
    17. Opie LH,
    18. Pfisterer M,
    19. Prescott E,
    20. Ruschitzka F,
    21. Sabate M,
    22. Senior R,
    23. Taggart DP,
    24. van der Wall EE,
    25. Vrints CJ,
    26. Guidelines ESCCfP,
    27. Zamorano JL,
    28. Achenbach S,
    29. Baumgartner H,
    30. Bax JJ,
    31. Bueno H,
    32. Dean V,
    33. Deaton C,
    34. Erol C,
    35. Fagard R,
    36. Ferrari R,
    37. Hasdai D,
    38. Hoes AW,
    39. Kirchhof P,
    40. Knuuti J,
    41. Kolh P,
    42. Lancellotti P,
    43. Linhart A,
    44. Nihoyannopoulos P,
    45. Piepoli MF,
    46. Ponikowski P,
    47. Sirnes PA,
    48. Tamargo JL,
    49. Tendera M,
    50. Torbicki A,
    51. Wijns W,
    52. Windecker S,
    53. Document R,
    54. Knuuti J,
    55. Valgimigli M,
    56. Bueno H,
    57. Claeys MJ,
    58. Donner-Banzhoff N,
    59. Erol C,
    60. Frank H,
    61. Funck-Brentano C,
    62. Gaemperli O,
    63. Gonzalez-Juanatey JR,
    64. Hamilos M,
    65. Hasdai D,
    66. Husted S,
    67. James SK,
    68. Kervinen K,
    69. Kolh P,
    70. Kristensen SD,
    71. Lancellotti P,
    72. Maggioni AP,
    73. Piepoli MF,
    74. Pries AR,
    75. Romeo F,
    76. Ryden L,
    77. Simoons ML,
    78. Sirnes PA,
    79. Steg PG,
    80. Timmis A,
    81. Wijns W,
    82. Windecker S,
    83. Yildirir A,
    84. Zamorano JL
    : 2013 esc guidelines on the management of stable coronary artery disease: The task force on the management of stable coronary artery disease of the european society of cardiology. Eur Heart J 34(38): 2949-3003, 2013.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Pelgrim GJ,
    2. Dorrius M,
    3. Xie X,
    4. den Dekker MA,
    5. Schoepf UJ,
    6. Henzler T,
    7. Oudkerk M,
    8. Vliegenthart R
    : The dream of a one-stop-shop: Meta-analysis on myocardial perfusion ct. Eur J Radiol 84(12): 2411-2420, 2015.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ko SM,
    2. Choi JW,
    3. Hwang HK,
    4. Song MG,
    5. Shin JK,
    6. Chee HK
    : Diagnostic performance of combined noninvasive anatomic and functional assessment with dual-source ct and adenosine-induced stress dual-energy ct for detection of significant coronary stenosis. AJR Am J Roentgenol 198(3): 512-520, 2012.
    OpenUrlCrossRefPubMed
    1. Wang R,
    2. Yu W,
    3. Wang Y,
    4. He Y,
    5. Yang L,
    6. Bi T,
    7. Jiao J,
    8. Wang Q,
    9. Chi L,
    10. Yu Y,
    11. Zhang Z
    : Incremental value of dual-energy ct to coronary ct angiography for the detection of significant coronary stenosis: Comparison with quantitative coronary angiography and single photon emission computed tomography. Int J Cardiovasc Imaging 27(5): 647-656, 2011.
    OpenUrlCrossRefPubMed
    1. De Cecco CN,
    2. Harris BS,
    3. Schoepf UJ,
    4. Silverman JR,
    5. McWhite CB,
    6. Krazinski AW,
    7. Bayer RR,
    8. Meinel FG
    : Incremental value of pharmacological stress cardiac dual-energy ct over coronary ct angiography alone for the assessment of coronary artery disease in a high-risk population. AJR Am J Roentgenol 203(1): W70-77, 2014.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Meinel FG,
    2. De Cecco CN,
    3. Schoepf UJ,
    4. Nance JW Jr..,
    5. Silverman JR,
    6. Flowers BA,
    7. Henzler T
    : First-arterial-pass dual-energy ct for assessment of myocardial blood supply: Do we need rest, stress, and delayed acquisition? Comparison with spect. Radiology 270(3): 708-716, 2014.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Leipsic J,
    2. Abbara S,
    3. Achenbach S,
    4. Cury R,
    5. Earls JP,
    6. Mancini GJ,
    7. Nieman K,
    8. Pontone G,
    9. Raff GL
    : Scct guidelines for the interpretation and reporting of coronary ct angiography: A report of the society of cardiovascular computed tomography guidelines committee. J Cardiovasc Comput Tomogr 8(5): 342-358, 2014.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Douglas PS,
    2. Pontone G,
    3. Hlatky MA,
    4. Patel MR,
    5. Norgaard BL,
    6. Byrne RA,
    7. Curzen N,
    8. Purcell I,
    9. Gutberlet M,
    10. Rioufol G,
    11. Hink U,
    12. Schuchlenz HW,
    13. Feuchtner G,
    14. Gilard M,
    15. Andreini D,
    16. Jensen JM,
    17. Hadamitzky M,
    18. Chiswell K,
    19. Cyr D,
    20. Wilk A,
    21. Wang F,
    22. Rogers C,
    23. De Bruyne B
    : Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. Usual care in patients with suspected coronary artery disease: The prospective longitudinal trial of ffr(ct): Outcome and resource impacts study. Eur Heart J 36(47): 3359-3367, 2015.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cannao PM,
    2. Schoepf UJ,
    3. Muscogiuri G,
    4. Wichmann JL,
    5. Fuller SR,
    6. Secchi F,
    7. Varga-Szemes A,
    8. De Cecco CN
    : Technical prerequisites and imaging protocols for dynamic and dual energy myocardial perfusion imaging. Eur J Radiol 84(12): 2401-2410, 2015.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Osawa K,
    2. Miyoshi T,
    3. Miki T,
    4. Koyama Y,
    5. Sato S,
    6. Kanazawa S,
    7. Ito H
    : Diagnostic performance of first-pass myocardial perfusion imaging without stress with computed tomography (ct) compared with coronary ct angiography alone, with fractional flow reserve as the reference standard. PLoS One 11(2): e0149170, 2016.
    OpenUrl
  9. ↵
    1. Meyer M,
    2. Haubenreisser H,
    3. Schoepf UJ,
    4. Vliegenthart R,
    5. Leidecker C,
    6. Allmendinger T,
    7. Lehmann R,
    8. Sudarski S,
    9. Borggrefe M,
    10. Schoenberg SO,
    11. Henzler T
    : Closing in on the k edge: Coronary ct angiography at 100, 80, and 70 kv-initial comparison of a second- versus a third-generation dual-source ct system. Radiology 273(2): 373-382, 2014.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Coenen A,
    2. Rossi A,
    3. Lubbers MM,
    4. Kurata A,
    5. Kono AK,
    6. Chelu RG,
    7. Segreto S,
    8. Dijkshoorn ML,
    9. Wragg A,
    10. van Geuns RM,
    11. Pugliese F,
    12. Nieman K
    : Integrating ct myocardial perfusion and ct-ffr in the work-up of coronary artery disease. JACC Cardiovasc Imaging 10(7): 760-770, 2017.
    OpenUrlAbstract/FREE Full Text
    1. Genders TS,
    2. Steyerberg EW,
    3. Alkadhi H,
    4. Leschka S,
    5. Desbiolles L,
    6. Nieman K,
    7. Galema TW,
    8. Meijboom WB,
    9. Mollet NR,
    10. de Feyter PJ,
    11. Cademartiri F,
    12. Maffei E,
    13. Dewey M,
    14. Zimmermann E,
    15. Laule M,
    16. Pugliese F,
    17. Barbagallo R,
    18. Sinitsyn V,
    19. Bogaert J,
    20. Goetschalckx K,
    21. Schoepf UJ,
    22. Rowe GW,
    23. Schuijf JD,
    24. Bax JJ,
    25. de Graaf FR,
    26. Knuuti J,
    27. Kajander S,
    28. van Mieghem CA,
    29. Meijs MF,
    30. Cramer MJ,
    31. Gopalan D,
    32. Feuchtner G,
    33. Friedrich G,
    34. Krestin GP,
    35. Hunink MG,
    36. Consortium CAD
    : A clinical prediction rule for the diagnosis of coronary artery disease: Validation, updating, and extension. Eur Heart J 32(11): 1316-1330, 2011.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo: 31 (6)
In Vivo
Vol. 31, Issue 6
November-December 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Impact of Rest Dual–energy Computed Tomography Myocardial Perfusion in Patients with Coronary Artery Disease
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Impact of Rest Dual–energy Computed Tomography Myocardial Perfusion in Patients with Coronary Artery Disease
STEFAN BAUMANN, MARLON RUTSCH, TOBIAS BECHER, PHILIPP KRYEZIU, HOLGER HAUBENREISSER, NILS VOGLER, CELI ANNE SCHOENIKE, MARTIN BORGGREFE, STEFAN O. SCHOENBERG, IBRAHIM AKIN, THOMAS HENZLER, DIRK LOSSNITZER
In Vivo Nov 2017, 31 (6) 1153-1157;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Impact of Rest Dual–energy Computed Tomography Myocardial Perfusion in Patients with Coronary Artery Disease
STEFAN BAUMANN, MARLON RUTSCH, TOBIAS BECHER, PHILIPP KRYEZIU, HOLGER HAUBENREISSER, NILS VOGLER, CELI ANNE SCHOENIKE, MARTIN BORGGREFE, STEFAN O. SCHOENBERG, IBRAHIM AKIN, THOMAS HENZLER, DIRK LOSSNITZER
In Vivo Nov 2017, 31 (6) 1153-1157;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study
  • Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy
  • Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
Show more Clinical Studies

Similar Articles

Keywords

  • Coronary CT angiography
  • Coronary artery disease
  • myocardial perfusion imaging
  • dual-energy CT
  • myocardial ischemia
In Vivo

© 2022 In Vivo

Powered by HighWire